Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision numbers in the page footer were updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved a general government funding and operating status notice that previously appeared on the page header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedUI update to the Record History page shows an extended list of submission versions for NCT03635983, adding more version entries and updated navigation. No changes to the trial data, status, or results are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference8%

- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.